Aalborg

• PHASE II STUDY OF AZACITIDINE IN COMBINATION WITH LOW DOSE INTENSITY VENETOCLAX IN PATIENTS WITH ACUTE MYELOID LEUKEMIA WITH INTEGRATION OF … Recruiting
  2023-510415-19-00 4 2024-08-28 Acute Myeloid Leukemia
• The LIFE-MET Study: Lifestyle intervention and Metformin in early puberty. Recruiting
  2024-511009-50-00 4 2024-08-27 Precocious puberty and overweight
• An ascending dose study to determine the safety and effect of antibodies against hepatitis B (The SAMBA Study) Recruiting
  2023-508444-22-01 1 2024-08-26 Chronic hepatitis B infection
• Naldemedine OIBD Recruiting
  2023-507744-36-00 4 2024-08-12 Opioid induced bowel dysfunction
• Short course antibiotic treatment of Gram-negative bacteremia: A multicenter, randomized, non-blinded, non-inferiority interventional study Recruiting
  2024-514900-16-00 6 2024-07-25 Gram-negative Bacteremia
• HEMODIALYSIS AND ANTIBIOTIC PROPHYLAXIS Recruiting
  2024-515001-26-00 6 2024-07-25 Blood poisoning in patients with renal failure treated with hemodialys
• Clinical trial of MK-2870 in combination with pembrolizumab in people who have had surgery to treat triple negative breast cancer Recruiting
  2023-504962-52-00 5 2024-07-10 Triple negative breast cancer.
• New treatments to reduce cardiovascular disease in type 1 diabetes Recruiting
  2023-505794-32-04 5 2024-07-05 Type 1 diabetes
• A Study Evaluating the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered-Dose Inhaler on Cardiopulmonary Outcomes in C … Recruiting
  2023-507407-59-00 5 2024-07-04 Chronic Obstructive Pulmonary Disease (COPD)
• A Phase 3, Randomized, Open-Label Study of Combination Therapy with Avutometinib plus Defactinib Versus Investigator’s Choice of Treatment i … Recruiting
  2023-508204-38-00 5 2024-07-02 Recurrent Low-Grade Serous Ovarian Cancer (LGSOC)
• Intrapleural Fibrinolysis and DNase versus VATS for the treatment of pleural empyema: a randomized, controlled trial Recruiting
  2024-513596-40-00 6 2024-06-28 Pleural empyema
• BeDry Recruiting
  2023-510187-13-00 5 2024-06-27 Daytime urinary incontinence and overactive bladder
• IMPACT – the introduction of mycotic prophylaxis at cystectomy trial. Recruiting
  2023-506226-36-00 6 2024-06-23 Fungal infection
• A Phase 3, Randomized Study to Compare Nemtabrutinib Versus Comparator (Investigator’s Choice of Ibrutinib or Acalabrutinib) in Participants … Recruiting
  2022-501697-19-01 5 2024-06-18 Small Lymphocytic Lymphoma (SLL) / Untreated Chronic Lymphocytic Leuke
• Safety and diagnostic performance of uPAR PET imaging in localised, untreated prostate cancer. Recruiting
  2023-507111-35-00 9 2024-06-03 Prostate Cancer
• C1071032 - MAGNETISMM-32 A PHASE 3, OPEN-LABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMB, POMALIDOMIDE, DEXAMETHASONE (EPd) OR POMAL … Recruiting
  2023-507871-23-00 5 2024-05-27 Relapsed/Refractory Multiple Myeloma
• Tocilizumab for Painful Chronic Pancreatitis (TOPAC-trial) Recruiting
  2023-510084-35-00 4 2024-05-21 Chronic pancreatitis
• HOVON 165 CLL: A prospective randomized phase I/II trial of venetoclax treatment (26 cycles) with 6 cycles or 12 cycles of epcoritamab in pa … Recruiting
  2022-500305-40-00 9 2024-04-10 Small Lymphocytic Lymphoma
• A clinical study to compare MK-2870 with pembrolizumab to pembrolizumab alone in people with lung cancer (MK-2870-007) Recruiting
  2023-503376-24-00 5 2024-03-20 Metastatic non-small cell lung cancer (NSCLC)
• Can patients with atrial fibrillation discontinue anticoagulant therapy after cardiac surgery: The ATLAAC trial Recruiting
  2022-502986-92-00 6 2024-02-27 Atrial fibrillation
• SAVE- oral antibiotics for treatment of vertebral osteomyelitis Recruiting
  2023-507617-96-01 6 2024-02-14 Pyogenic vertebral osteomyelitis
• DAN-WAR-D - Danish Warfarin-Dialysis Study: Safety and efficacy of warfarin in patients with atrial fibrillation on dialysis -A nationwide p … Recruiting
  2022-502500-75-00 6 2024-01-30 Atrial fibrillation
• LiBRA – Lithium treatment to prevent cognitive impairment after brain radiotherapy. Recruiting
  2023-504071-24-00 4 2023-11-07 Brain tumor
• A randomized phase II study of gemcitabine versus reduced-dose combination chemotherapy in fragile patients with non-resectable pancreatic c … Recruiting
  2024-514291-41-00 4 2023-10-20 Pancreatic cancer

Showing 121–144 of 319 trials